Post-hepatectomy tolvaptan-induced hypernatremia in a hepatocellular carcinoma patient with cirrhosis: a case report

BACKGROUND: Tolvaptan is used in Japan to reduce fluid retention caused by cirrhosis. However, hypernatremia is one of the most important side effects. This report is the first case report of a patient who developed hypernatremia after tolvaptan administration in the early stages following hepatecto...

Descripción completa

Detalles Bibliográficos
Autores principales: Iida, Hiroya, Maehira, Hiromitsu, Mori, Haruki, Maekawa, Tsuyoshi, Tani, Masaji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105548/
https://www.ncbi.nlm.nih.gov/pubmed/32232601
http://dx.doi.org/10.1186/s40792-020-00825-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105548/
https://www.ncbi.nlm.nih.gov/pubmed/32232601
http://dx.doi.org/10.1186/s40792-020-00825-w

Ejemplares similares